chr2-44320435-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BA1

The NM_000341.4(SLC3A1):​c.1854G>A​(p.Met618Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.648 in 1,613,640 control chromosomes in the GnomAD database, including 349,250 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.53 ( 24251 hom., cov: 33)
Exomes 𝑓: 0.66 ( 324999 hom. )

Consequence

SLC3A1
NM_000341.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1B:5

Conservation

PhyloP100: -0.144
Variant links:
Genes affected
SLC3A1 (HGNC:11025): (solute carrier family 3 member 1) This gene encodes a type II membrane glycoprotein which is one of the components of the renal amino acid transporter which transports neutral and basic amino acids in the renal tubule and intestinal tract. Mutations and deletions in this gene are associated with cystinuria. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
PREPL (HGNC:30228): (prolyl endopeptidase like) The protein encoded by this gene belongs to the prolyl oligopeptidase subfamily of serine peptidases. Mutations in this gene have been associated with hypotonia-cystinuria syndrome, also known as the 2p21 deletion syndrome. Several alternatively spliced transcript variants encoding either the same or different isoforms have been described for this gene.[provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 25 curated pathogenic missense variants (we use a threshold of 10). The gene has 4 curated benign missense variants. Gene score misZ: -3.1434 (below the threshold of 3.09). Trascript score misZ: -3.2509 (below the threshold of 3.09). GenCC associations: The gene is linked to cystinuria, cystinuria type A.
BP4
Computational evidence support a benign effect (MetaRNN=3.6894764E-6).
BP6
Variant 2-44320435-G-A is Benign according to our data. Variant chr2-44320435-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 336214.We mark this variant Likely_benign, oryginal submissions are: {Pathogenic=1, Benign=5}. Variant chr2-44320435-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.673 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC3A1NM_000341.4 linkc.1854G>A p.Met618Ile missense_variant Exon 10 of 10 ENST00000260649.11 NP_000332.2 Q07837-1A0A0S2Z4E1
PREPLNM_001171613.2 linkc.*921C>T 3_prime_UTR_variant Exon 14 of 14 ENST00000409411.6 NP_001165084.1 Q4J6C6-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC3A1ENST00000260649.11 linkc.1854G>A p.Met618Ile missense_variant Exon 10 of 10 1 NM_000341.4 ENSP00000260649.6 Q07837-1
PREPLENST00000409411 linkc.*921C>T 3_prime_UTR_variant Exon 14 of 14 1 NM_001171613.2 ENSP00000387095.2 Q4J6C6-4
ENSG00000285542ENST00000649044.1 linkn.*1865G>A downstream_gene_variant ENSP00000497083.1 A0A3B3IS24

Frequencies

GnomAD3 genomes
AF:
0.535
AC:
81262
AN:
151978
Hom.:
24260
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.273
Gnomad AMI
AF:
0.770
Gnomad AMR
AF:
0.557
Gnomad ASJ
AF:
0.686
Gnomad EAS
AF:
0.314
Gnomad SAS
AF:
0.649
Gnomad FIN
AF:
0.582
Gnomad MID
AF:
0.639
Gnomad NFE
AF:
0.678
Gnomad OTH
AF:
0.567
GnomAD2 exomes
AF:
0.594
AC:
148070
AN:
249352
AF XY:
0.609
show subpopulations
Gnomad AFR exome
AF:
0.262
Gnomad AMR exome
AF:
0.514
Gnomad ASJ exome
AF:
0.683
Gnomad EAS exome
AF:
0.312
Gnomad FIN exome
AF:
0.592
Gnomad NFE exome
AF:
0.684
Gnomad OTH exome
AF:
0.627
GnomAD4 exome
AF:
0.660
AC:
964425
AN:
1461544
Hom.:
324999
Cov.:
50
AF XY:
0.662
AC XY:
481119
AN XY:
727116
show subpopulations
Gnomad4 AFR exome
AF:
0.262
AC:
8759
AN:
33474
Gnomad4 AMR exome
AF:
0.519
AC:
23213
AN:
44710
Gnomad4 ASJ exome
AF:
0.684
AC:
17860
AN:
26128
Gnomad4 EAS exome
AF:
0.357
AC:
14185
AN:
39692
Gnomad4 SAS exome
AF:
0.664
AC:
57314
AN:
86252
Gnomad4 FIN exome
AF:
0.598
AC:
31924
AN:
53406
Gnomad4 NFE exome
AF:
0.692
AC:
769561
AN:
1111734
Gnomad4 Remaining exome
AF:
0.624
AC:
37686
AN:
60382
Heterozygous variant carriers
0
18745
37489
56234
74978
93723
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
19352
38704
58056
77408
96760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.534
AC:
81251
AN:
152096
Hom.:
24251
Cov.:
33
AF XY:
0.529
AC XY:
39348
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.272
AC:
0.272217
AN:
0.272217
Gnomad4 AMR
AF:
0.556
AC:
0.556297
AN:
0.556297
Gnomad4 ASJ
AF:
0.686
AC:
0.686167
AN:
0.686167
Gnomad4 EAS
AF:
0.314
AC:
0.314043
AN:
0.314043
Gnomad4 SAS
AF:
0.649
AC:
0.649461
AN:
0.649461
Gnomad4 FIN
AF:
0.582
AC:
0.582307
AN:
0.582307
Gnomad4 NFE
AF:
0.678
AC:
0.677998
AN:
0.677998
Gnomad4 OTH
AF:
0.563
AC:
0.562854
AN:
0.562854
Heterozygous variant carriers
0
1735
3470
5205
6940
8675
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
700
1400
2100
2800
3500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.635
Hom.:
104648
Bravo
AF:
0.516
TwinsUK
AF:
0.698
AC:
2587
ALSPAC
AF:
0.694
AC:
2673
ESP6500AA
AF:
0.288
AC:
1270
ESP6500EA
AF:
0.676
AC:
5817
ExAC
AF:
0.596
AC:
72332
Asia WGS
AF:
0.475
AC:
1655
AN:
3478
EpiCase
AF:
0.692
EpiControl
AF:
0.686

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cystinuria Pathogenic:1Benign:3
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 10, 2023
Biotechnology Lab, University of Central Punjab
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

A molecular and computational study performed on the Pakistani population reported this missense variant (M618I) in the SLC3A1 gene, as a pathogenic variant, by using the technique of Next-generation sequencing. The variant was potentially involved in causing Cystinuria by altering the structural and functional effect of the rBAT protein coded by the SLC3A1 gene. The variant was confirmed by ARMS-PCR at the population level (Zafar & Awais, 2023). -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Jan 18, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.17
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
3.8
DANN
Benign
0.66
DEOGEN2
Benign
0.18
T;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.42
T;T;T
MetaRNN
Benign
0.0000037
T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.77
N;.;.
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.38
N;N;N
REVEL
Benign
0.15
Sift
Benign
0.34
T;T;T
Sift4G
Benign
0.35
T;T;T
Polyphen
0.0010
B;.;.
Vest4
0.042
MutPred
0.15
Loss of methylation at R619 (P = 0.0934);.;.;
MPC
0.0062
ClinPred
0.0026
T
GERP RS
-1.4
Varity_R
0.097
gMVP
0.50
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs698761; hg19: chr2-44547574; COSMIC: COSV53215689; COSMIC: COSV53215689; API